Immune Pharmaceuticals Company Profile (NASDAQ:IMNP)

About Immune Pharmaceuticals

Immune Pharmaceuticals logoImmune Pharmaceuticals Inc. is a United States-based clinical stage biopharmaceutical company. The Company is engaged in the development and commercialization of targeted therapeutics, including monoclonal antibodies, nano-therapeutics and antibody drug conjugates, for the treatment of inflammatory diseases and cancer. Its pipeline includes, Bertilimumab, which is a clinical-stage human antibody, targeting eotaxin-1, which is involved in a number of immune mediated diseases; NanomAbs, which is a technology platform that allows the targeted delivery of chemotherapeutics into cancer cells, and AmiKet, which is a topical neuropathic pain drug candidate. The Company's oncology pipeline includes Crolibulin, which is a small molecule vascular disrupting agent and apoptosis inducer for the intended treatment of patients with solid tumors, and Azixa, which is a vascular disruptive agent in development for the treatment of primary brain cancers and metastatic tumors with brain involvement.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: IMNP
  • CUSIP:
Key Metrics:
  • Previous Close: $0.34
  • 50 Day Moving Average: $0.4011
  • 200 Day Moving Average: $0.4143
  • 52-Week Range: $0.20 - $1.62
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 11.17
  • P/E Growth: 0.0000
  • Market Cap: $26.53M
  • Outstanding Shares: 79,178,000
  • Beta: 1.45
Additional Links:
Companies Related to Immune Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Immune Pharmaceuticals (NASDAQ:IMNP) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $6.25 (1,765.11% upside)

Analysts' Ratings History for Immune Pharmaceuticals (NASDAQ:IMNP)
Show:
DateFirmActionRatingPrice TargetDetails
8/18/2016FBR & CoReiterated RatingBuyView Rating Details
5/16/2016Chardan CapitalReiterated RatingBuyView Rating Details
4/4/2016Roth CapitalReiterated RatingBuyView Rating Details
6/11/2015MLV & Co.Initiated CoverageBuy$6.00View Rating Details
(Data available from 8/30/2014 forward)

Earnings

Earnings History for Immune Pharmaceuticals (NASDAQ:IMNP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/10/2016        
8/16/2016Q2($0.13)($0.13)ViewN/AView Earnings Details
5/16/2016Q116($0.15)($0.17)ViewN/AView Earnings Details
11/12/2015Q315($0.18)($0.35)ViewListenView Earnings Details
8/17/2015Q215($0.22)($0.12)ViewN/AView Earnings Details
5/18/2015Q1($0.20)($0.15)ViewN/AView Earnings Details
4/15/2015($0.37)($0.34)ViewN/AView Earnings Details
8/14/2014($0.21)($0.27)ViewN/AView Earnings Details
5/22/2014($0.15)($0.35)ViewN/AView Earnings Details
4/11/2014($0.15)($0.29)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Immune Pharmaceuticals (NASDAQ:IMNP)
Current Year EPS Consensus Estimate: $-0.5600 EPS
Next Year EPS Consensus Estimate: $0.0300 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.15)($0.15)($0.15)
Q2 20161($0.14)($0.14)($0.14)
Q3 20162($0.14)($0.13)($0.14)
Q4 20162($0.15)($0.11)($0.13)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Immune Pharmaceuticals (NASDAQ:IMNP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Immune Pharmaceuticals (NASDAQ:IMNP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/4/2016Daniel Gedeon TeperCEOBuy937,500$0.38$356,250.00View SEC Filing  
8/4/2016Daniel KazadoDirectorBuy666,667$0.45$300,000.15View SEC Filing  
8/4/2016Monica E LuchiCMOBuy777,778$0.45$350,000.10View SEC Filing  
1/26/2016Daniel Gedeon TeperCEOBuy42,000$0.59$24,780.00View SEC Filing  
1/19/2016Daniel Gedeon TeperCEOBuy44,200$0.57$25,194.00View SEC Filing  
1/12/2016Daniel Gedeon TeperCEOBuy39,400$0.62$24,428.00View SEC Filing  
1/5/2016Daniel Gedeon TeperCEOBuy62,000$0.81$50,220.00View SEC Filing  
12/7/2015Daniel Gedeon TeperCEOBuy65,400$0.76$49,704.00View SEC Filing  
12/7/2015Daniel KazadoDirectorBuy150,000$0.78$117,000.00View SEC Filing  
10/26/2015Daniel Gedeon TeperCEOBuy18,400$1.36$25,024.00View SEC Filing  
10/19/2015Daniel Gedeon TeperCEOBuy18,600$1.34$24,924.00View SEC Filing  
10/12/2015Daniel Gedeon TeperCEOBuy19,000$1.30$24,700.00View SEC Filing  
10/5/2015Daniel Gedeon TeperCEOBuy40,700$1.23$50,061.00View SEC Filing  
9/14/2015Rene Pierre AzriaDirectorBuy50,000$1.48$74,000.00View SEC Filing  
9/1/2015Daniel Gedeon TeperCEOBuy7,569$1.29$9,764.01View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Immune Pharmaceuticals (NASDAQ:IMNP)
DateHeadline
finance.yahoo.com logoIMMUNE PHARMACEUTICALS INC Financials (NASDAQ:IMNP)
finance.yahoo.com - August 24 at 5:30 PM
News IconFirst Pacific Advisors buys $281669172 stake in Thermo Fisher Scientific (TMO) (NASDAQ:IMNP)
myhealthbowl.com - August 20 at 9:48 AM
biz.yahoo.com logoIMMUNE PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:IMNP)
biz.yahoo.com - August 18 at 5:38 PM
News IconNoble Corporation Ordinary Shares (NYSE:NE) & Immune Pharmaceuticals (NASDAQ:IMNP) Investor's Alert - Money News (press release) (NASDAQ:IMNP)
www.newsismoney.com - August 17 at 5:50 PM
News IconStock Earnings in Review: Immune Pharmaceuticals Inc (NASDAQ:IMNP) - Post Registrar (NASDAQ:IMNP)
postregistrar.com - August 17 at 5:50 PM
News IconHvad skete der lige der? (NASDAQ:IMNP)
www.euroinvestor.dk - August 16 at 5:48 PM
finance.yahoo.com logoImmune Pharmaceuticals Provides Business and R&D Update and Announces Second Quarter 2016 Financial Results (NASDAQ:IMNP)
finance.yahoo.com - August 16 at 11:51 AM
biz.yahoo.com logoIMMUNE PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report (NASDAQ:IMNP)
biz.yahoo.com - August 15 at 8:47 PM
News IconAnalysts Review on Earnings Estimates: Immune Pharmaceuticals Inc (NASDAQ:IMNP) - Post Registrar (NASDAQ:IMNP)
postregistrar.com - August 15 at 3:16 PM
4-traders.com logoLife Clips : Earnings Season is Here and These 4 Companies Deserve Your Attention (NASDAQ:IMNP)
www.4-traders.com - August 11 at 5:53 PM
News IconFriendable, Inc. (OTC Pink: FDBL) – Re-Signs TKA – More Celebrity Endorsements, Adds Consumer Brand Partnerships (NASDAQ:IMNP)
ih.advfn.com - August 11 at 5:53 PM
News IconHigh Volume Healthcare Stocks Movements: Merck & Co., Inc. (NYSE:MRK), Immune Pharmaceuticals, Inc. (NASDAQ ... - TWN (NASDAQ:IMNP)
thewellesleysnews.com - August 10 at 8:32 AM
streetupdates.com logoAnalysts Review of Stocks: Immune Pharmaceuticals Inc. (NASDAQ:IMNP) , Sarepta Therapeutics, Inc. (NASDAQ:SRPT) - Street Updates (NASDAQ:IMNP)
www.streetupdates.com - August 9 at 5:48 PM
News IconHigh Volume Healthcare Stocks: Immune Pharmaceuticals, Inc. (NASDAQ:IMNP), MEI Pharma, Inc. (NASDAQ:MEIP) - TWN (NASDAQ:IMNP)
thewellesleysnews.com - August 9 at 5:48 PM
seekingalpha.com logoImmune Pharmaceuticals: The Million Dollar Mistake - Seeking Alpha (NASDAQ:IMNP)
seekingalpha.com - August 9 at 5:48 PM
News IconHC Stocks to Path: Immune Pharmaceuticals Inc (NASDAQ:IMNP) Celgene Corporation (NASDAQ:CELG) - share market updates (press release) (NASDAQ:IMNP)
sharemarketupdates.com - August 9 at 8:38 AM
News IconOppe med 7% i pm (NASDAQ:IMNP)
www.euroinvestor.dk - August 8 at 5:50 PM
News IconCEO of Immune Pharmaceuticals Inc (NASDAQ:IMNP), Teper Daniel Gedeon, buys 937,500 shares worth $356,250 (NASDAQ:IMNP)
empowerednews.net - August 5 at 5:45 PM
istreetwire.com logo3 Stocks in Focus: Under Armour, Inc. (UA), Immune Pharmaceuticals, Inc. (IMNP), Cray Inc. (CRAY) - iStreetWire (NASDAQ:IMNP)
istreetwire.com - August 5 at 8:35 AM
streetupdates.com logoStocks within Traders Radar: Endo International plc (NASDAQ:ENDP) , Immune Pharmaceuticals Inc. (NASDAQ:IMNP) - Street Updates (NASDAQ:IMNP)
www.streetupdates.com - August 5 at 8:35 AM
fortune.com logoAnalyst Views That Are Worth Watching: Immune Pharmaceuticals Inc (NASDAQ:IMNP), Cray Inc. (NASDAQ:CRAY) - Review Fortune (NASDAQ:IMNP)
reviewfortune.com - August 5 at 8:35 AM
gurufocus.com logoImmune Pharmaceuticals Inc (IMNP) CEO Daniel Gedeon Teper Bought $356250 of Stocks - GuruFocus.com (NASDAQ:IMNP)
www.gurufocus.com - August 5 at 8:35 AM
finance.yahoo.com logoImmune Pharmaceuticals Inc (IMNP) CEO Daniel Gedeon Teper Bought $356,250 of Stocks (NASDAQ:IMNP)
finance.yahoo.com - August 5 at 8:35 AM
istreetwire.com logoTraders Recap: Evoke Pharma, Inc. (EVOK), Immune Pharmaceuticals, Inc. (IMNP), InvenSense, Inc. (INVN) - iStreetWire (NASDAQ:IMNP)
istreetwire.com - August 4 at 8:38 AM
istreetwire.com logoTraders Recap: Evoke Pharma, Inc. (EVOK), Immune Pharmaceuticals, Inc. (IMNP), InvenSense, Inc. (INVN) (NASDAQ:IMNP)
istreetwire.com - August 3 at 5:56 PM
biz.yahoo.com logoIMMUNE PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equit (NASDAQ:IMNP)
biz.yahoo.com - August 3 at 5:56 PM
streetupdates.com logoNoteworthy Analyst's Rating to Observe: Boston Scientific Corporation (NYSE:BSX) , Immune Pharmaceuticals Inc ... - Street Updates (NASDAQ:IMNP)
www.streetupdates.com - July 27 at 8:26 AM
News IconStock under consideration: Immune Pharmaceuticals, Inc. (NASDAQ:IMNP) - News Oracle (NASDAQ:IMNP)
www.newsoracle.com - July 27 at 8:26 AM
istreetwire.com logoStocks Trending Alert: Ross Stores Inc. (ROST), Immune Pharmaceuticals, Inc. (IMNP), Raytheon Company (RTN) - iStreetWire (NASDAQ:IMNP)
istreetwire.com - July 26 at 8:34 AM
streetupdates.com logoPreview of Analysts Recommendation: Bristol-Myers Squibb Company (NYSE:BMY) , Immune Pharmaceuticals Inc ... - Street Updates (NASDAQ:IMNP)
www.streetupdates.com - July 26 at 8:34 AM
streetupdates.com logoReview of Analysts Ranking: Novavax, Inc. (NASDAQ:NVAX) , Immune Pharmaceuticals Inc. (NASDAQ:IMNP) - Street Updates (NASDAQ:IMNP)
www.streetupdates.com - July 26 at 8:34 AM
fortune.com logoCurrent Immune Pharmaceuticals, Inc. (NASDAQ:IMNP) PT Means Stock Is Worth Almost $3 - Review Fortune (NASDAQ:IMNP)
reviewfortune.com - July 26 at 8:34 AM
istreetwire.com logoStocks Buzz: Progressive (PGR), Immune Pharmaceuticals (IMNP) Twilio (TWLO) - iStreetWire (NASDAQ:IMNP)
istreetwire.com - July 22 at 8:35 AM
News IconAnalyst Recommendations Review: Immune Pharmaceuticals, Inc. (NASDAQ:IMNP) - News Oracle (NASDAQ:IMNP)
www.newsoracle.com - July 22 at 8:35 AM
streetupdates.com logoNotable Analyst's Ranking Preview: Abbott Laboratories (NYSE:ABT) , Immune Pharmaceuticals Inc. (NASDAQ:IMNP) - Street Updates (NASDAQ:IMNP)
www.streetupdates.com - July 20 at 3:38 PM
streetupdates.com logoAnalyst's Valuable Buzzers: Teva Pharmaceutical Industries Limited (NYSE:TEVA) , Immune Pharmaceuticals Inc ... - Street Updates (NASDAQ:IMNP)
www.streetupdates.com - July 20 at 8:37 AM
News IconEquity Roundup: Stock Performance Focus on Immune Pharmaceuticals Inc. (NASDAQ:IMNP) - Press Telegraph (NASDAQ:IMNP)
presstelegraph.com - July 20 at 8:37 AM
streetinsider.com logoImmune Pharma (IMNP) Enters Amended Agreement with NPT; Will Form Pain-Neurology Subsidiary - StreetInsider.com (NASDAQ:IMNP)
www.streetinsider.com - July 20 at 8:37 AM
biz.yahoo.com logoIMMUNE PHARMACEUTICALS INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Of (NASDAQ:IMNP)
biz.yahoo.com - July 19 at 5:09 PM
streetinsider.com logoImmune Pharma (IMNP) Enters Amended Agreement with NPT; Will Form Pain-Neurology Subsidiary (NASDAQ:IMNP)
www.streetinsider.com - July 19 at 11:43 AM
finance.yahoo.com logoIMMUNE Pharmaceuticals to Form Pain and Neurology Spin Off Company around AmiKet (NASDAQ:IMNP)
finance.yahoo.com - July 19 at 9:30 AM
News IconWere Analysts Bullish Immune Pharmaceuticals Inc (NASDAQ:IMNP) This Week? - Consumer Eagle (NASDAQ:IMNP)
www.consumereagle.com - July 18 at 10:52 AM
News IconPerformance watch list: Immune Pharmaceuticals, Inc. (NASDAQ:IMNP) - News Oracle (NASDAQ:IMNP)
www.newsoracle.com - July 18 at 10:52 AM
News IconImmune Pharmaceuticals Inc. (NASDAQ:IMNP) Wall Street Analyst Recommendation Outlook - Telanagana Press (NASDAQ:IMNP)
telanaganapress.com - July 14 at 9:07 AM
streetupdates.com logoNoteworthy Stocks: Endo International plc (NASDAQ:ENDP) , Immune Pharmaceuticals Inc. (NASDAQ:IMNP) - Street Updates (NASDAQ:IMNP)
www.streetupdates.com - July 14 at 9:07 AM
News IconImmune Pharmaceuticals Inc (NASDAQ:IMNP) Warned Of Possible NASDAQ Delisting - Journal Transcript (NASDAQ:IMNP)
www.journaltranscript.com - July 14 at 9:07 AM
News IconWatching Unusual Volume on Shares of: Immune Pharmaceuticals, Inc. (NASDAQ:IMNP) - Engelwood Daily (NASDAQ:IMNP)
www.engelwooddaily.com - July 13 at 8:32 AM
fortune.com logoImmune Pharmaceuticals, Inc. (NASDAQ:IMNP) Insiders Look Optimistic About Prospects - Review Fortune (NASDAQ:IMNP)
reviewfortune.com - July 12 at 9:59 AM
News IconStock under consideration: Immune Pharmaceuticals (IMNP) - News Oracle (NASDAQ:IMNP)
www.newsoracle.com - July 12 at 9:59 AM
News IconCompany Stock Focus for Immune Pharmaceuticals Inc. (NASDAQ:IMNP): Which Way Will Shares Head? - Press Telegraph (NASDAQ:IMNP)
presstelegraph.com - July 11 at 5:42 PM

Social

Immune Pharmaceuticals (NASDAQ:IMNP) Chart for Tuesday, August, 30, 2016


Last Updated on 8/30/2016 by MarketBeat.com Staff